Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 126-150 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
manifestations of patients with COVID-19
Design:
Three-arm parallel groups randomized trial, with blinded (...) - COVID-19-patients would be studied in Shohadaye Pakdasht and Ziaeian hospitals. After applying the (...) criteria:
Inclusion criteria: Patients between 18 and 75 years of age with a probable diagnosis of COVID-19
Study aim:
Investigation of the effect of Lactocare® synbiotic on the prevention of COVID-19(...) who work where patients infected by COVID-19 are hospitalized. These participants are randomly (...) Reza hospital; active presence in the wards where patients with COVID-19 are hospitalized.
Exclusion
Symptoms in COVID-19 patients.
Design:
A randomized clinical trial with intervention / control and placebo (...) .
Settings and conduct:
The study population consists of all infected patients with COVID-19 that hospitalized or referred to Shahid Beheshti Hospital in Qom in 1399. An infected person with Covid-19 should be
its effects on immune cell balance as a therapeutic supplement in the treatment of COVID-19
Design (...) be performed on 40 COVID-19 patients which will be randomized using encoded sealed wax boxes.
Settings and conduct:
Patients are selected from the COVID-19 ward of Shahid Mohammadi Hospital in Bandar
Study aim:
The purpose of this study is immediate uses of convalescent covid-19 plasma in the (...) with the diagnosis and judgment of Covid-19. In the case group, plasma injection will be one of the first hospital treatment orders.
Participants/Inclusion and exclusion criteria:
Symptomatic COVID-19
Lopinavir/Ritanavir on respiratory involvement including Pneumonia and COViD-19 induced ARDS
comparison of (...) :
Clinic and Para clinic findings in COViD-19 patients.
Mortality and morbidity rate in COViD-19 patinets
Study aim:
Evaluation of the efficacy and safety of pentaglobin on patients with COVID-19 infection (...)COVID-19 and other inclusion criteria will be randomly divided in to intervention and control group.
Participants/Inclusion and exclusion criteria:
Patients who are diagnosed with COVID-19 by RT-PCR test and are
(COVID-19)
Design:
Clinical trial with control group, with parallel, randomized groups, phase 2-3 on 80 (...) conduct:
At Amin Hospital in Isfahan, 80 patients with COVID-19 were selected and the demographic and (...) recorded for all patients prior to hospitalization. The diagnostic criterion for COVID-19 in patients to
Study aim:
Evaluation of the role of naproxen as adjunctive therapy with standard therapies and its efficacy in the early improvement and reduced mortality rate of COVID-19 patients
Design:
In the blocking (...) the standard treatment provided in the latest national guide to COVID-19 disease.
Intervention group
of patients with COVID-19
Design:
This study is a single-center, prospective, randomized, open (...) . 3. Laboratory (RT-PCR) confirmation. 4.lung CT-Scan confirmation, which is typical for COVID-19(...) : Capsule Umifenovir 100mg, 2 Capsules every 6 hours, for 7 days (In addition to routine COVID-19 treatment
Study aim:
Evaluation of Trifluoperazine Effectiveness in Treatment of COVID-19 Patients
Design (...) :
All of the patients admitted to Razi hospital,Rasht, diagnosed for COVID-19 in April-March 2020,equal (...) with current medications, pregnancy and breast-feeding, previous COVID-19 treatment, bradycardia with
have written consciously and freely consent to participate in the study.
Confirmed diagnosis of COVID-19, with Laboratory (RT-PCR) confirmation.
Confirmed diagnosis of COVID-19, with lung CT-Scan result, which is typical for COVID-19 pulmonary involvement.
The patient has clinical symptom of COVID-19 (dry
Study aim:
Evaluation of the therapeutic role of plasmapheresis in patients with COVID-19 and its (...)COVID-19 disease.
Settings and conduct:
A total of 45 patients with COVID-19 admitted to the COVID-19(...) plasmapheresis in patients with severe COVID-19.
Main outcome variables:
Blood oxygen level, body temperature
the hospitals of the AJA University of Medical Sciences in 2022 due to Covid-19. The main referral (...) 2022 due to Covid-19. The main referral environment is COVID clinics.
Inclusion criteria, Confirmed (...) prolonged Covid syndrome
Design:
In COVID Clinic, Two groups of COVID patients are matched in terms of age
Immunoglobulin-enriched solution on COVID-19 Patients
Design:
A hospital-based, parallel-group, single-blind (...)
Intervention groups:
Intervention group 1 & 2: Suspected COVID-19 Patients who meet all of the following characteristics:
1- Patients with clinical signs of COVID-19
2- The positive CT scan
3- A Positive RT-PCR Test
hospitalized COVID-19 patients
Design:
Before-after clinical trial, single group, without randomization and blinding
Settings and conduct:
This study will be performed on patients with severe COVID-19 hospitalized (...) who all receive hydroxyurea tablets (500 mg three times a day) in addition to the usual COVID-19
patients with COVID-19 bedridden in Hazrat Fatemeh's Hospital
Design:
The clinical trial with a control (...) .
Settings and conduct:
The study will be performed on patients with Covid-19 hospitalized inHazrat Fatemeh's (...)Covid disease. At the beginning and before the intervention, a blood sample is taken to determine the
.
Participants/Inclusion and exclusion criteria:
Inclusion criteria:
Definitive diagnosis of Covid19 ; Having (...) Study aim:
Determining the effect of fluoxetine on ESR and CRP levels in covid disease patients
Design:
A clinical trial with a control group, with parallel groups, one-way blind, randomized, phase 3
patients with Covid-19 admitted to intensive care units
Design:
Clinical trial with control group, with (...) from the intensive care unit, as well as the rate of recovery of clinical symptoms of Covid-19, the (...) with Covid-19 admitted to the intensive care unit will be included. Patients with high blood pressure
among patients with COVID-19 disease
Design:
Three-group, randomized, phase two clinical trial on 45 (...) -19 Patients' ward in Allameh Behlool Gonabadi Hospital; Patients: who is affected by COVID-19 disease (...) criteria:
Inclusion criteria:
Willingness to participate in the study;
Hospitalized in COVID-19 ward of
Covid-19 referred to Shahid Beheshti Hospital in Hamadan in 2020-2021
Design:
This is a non blind (...)Covid19 (RT-PCR) candidate for outpatient treatment with pulmonary involvement score on CT scan equal to or below 8,Patients suspected of Covid-19 based on clinical signs and manifestations of CT scan
treatment of admitted patients with covid-19 infection, in order to find the better and safer treatment for (...) /Inclusion and exclusion criteria:
the patients with covid19 infection who admitted in one of university (...)covid19 and confirmed with Rt-PCR or lung Ct findings.
treaement regimen consisting of Atazanavir
Study aim:
Effect of dimethyl sulfoxide (DMSO) and ethanol solution in the prevention of COVID-19 patients
Design:
A clinical trial with a control group, with parallel groups, triple-blind, randomized (...) . COVID-19 incidence in prevention phase
in patients with ARDS induced by COVID-19.
Design:
Randomized clinical trial with control group (...) 18 years of age, confirmation of COVID-19 by PCR with imaging findings
Non-inclusion criteria (...) treatment protocol of COVID-19 plus subcutaneous injection of Anaxaparin 1 mg per kg (15 patients).
Control
members of COVID-19 patients
2. To determine the effect of oral supplementation by 25(OH)D on serum (...) will perform in as COVID-19 centers affiliated to the Tehran University of medical sciences.
Subjects include health providers and the patients' relatives with negative COVID-19.
Subjects will be allocated